Biologics: Targets and Therapy
Volume 15, 2021 - Issue
Open access
177
Views
6
CrossRef citations to date
0
Altmetric
Original Research
Switching and Discontinuation Patterns Among Patients Stable on Originator Infliximab Who Switched to an Infliximab Biosimilar or Remained on Originator Infliximab
Timothy Fitzgerald1 Real World Value & Evidence, Janssen Scientific Affairs, LLC, Titusville, New Jersey, USAView further author information
, Richard Melsheimer2 Medical Affairs, Janssen Biologics BV, Leiden, the Netherlandshttps://orcid.org/0000-0002-8378-5186View further author information
, Marie-Hélène Lafeuille3 Analysis Group, Inc., Montréal, Québec, CanadaView further author information
, Patrick Lefebvre3 Analysis Group, Inc., Montréal, Québec, CanadaView further author information
, Laura Morrison3 Analysis Group, Inc., Montréal, Québec, CanadaView further author information
, Kimberly Woodruff1 Real World Value & Evidence, Janssen Scientific Affairs, LLC, Titusville, New Jersey, USAView further author information
, Iris Lin1 Real World Value & Evidence, Janssen Scientific Affairs, LLC, Titusville, New Jersey, USAView further author information
& Bruno Emond3 Analysis Group, Inc., Montréal, Québec, CanadaCorrespondence[email protected]
View further author information
show allView further author information
Pages 1-15
|
Published online: 06 Jan 2021
Reprints and Permissions
Permission is granted subject to the terms of the License under which the work was published. Permission will be required if your reuse is not covered by the terms of the License.
To request a reprint or commercial or derivative permissions for this article, please click on the relevant link below.
For more information please visit our Permissions help page.
Related research
People also read lists articles that other readers of this article have read.
Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.
Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.